000 | 01876 a2200541 4500 | ||
---|---|---|---|
005 | 20250514155158.0 | ||
264 | 0 | _c20040416 | |
008 | 200404s 0 0 eng d | ||
022 | _a1526-632X | ||
024 | 7 |
_a10.1212/wnl.61.6.839 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVallée, J-N | |
245 | 0 | 0 |
_aAcute basilar artery occlusion treated by thromboaspiration in a cocaine and ecstasy abuser. _h[electronic resource] |
260 |
_bNeurology _cSep 2003 |
||
300 |
_a839-41 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAbciximab |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
650 | 0 | 4 | _aCatheterization |
650 | 0 | 4 |
_aCerebral Hemorrhage _xprevention & control |
650 | 0 | 4 |
_aCocaine _xadverse effects |
650 | 0 | 4 |
_aCocaine-Related Disorders _xcomplications |
650 | 0 | 4 |
_aComa _xetiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xtherapeutic use |
650 | 0 | 4 |
_aN-Methyl-3,4-methylenedioxyamphetamine _xadverse effects |
650 | 0 | 4 |
_aPons _xblood supply |
650 | 0 | 4 |
_aSerotonin _xphysiology |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aSubstance-Related Disorders _xcomplications |
650 | 0 | 4 |
_aSuction _xinstrumentation |
650 | 0 | 4 |
_aThrombectomy _xinstrumentation |
650 | 0 | 4 |
_aThrombophilia _xchemically induced |
650 | 0 | 4 |
_aVasospasm, Intracranial _xchemically induced |
650 | 0 | 4 |
_aVertebrobasilar Insufficiency _xdrug therapy |
700 | 1 | _aCrozier, S | |
700 | 1 | _aGuillevin, R | |
700 | 1 | _aObadia, M | |
700 | 1 | _aLo, D | |
700 | 1 | _aBarragan-Campos, H M | |
700 | 1 | _aSamson, Y | |
700 | 1 | _aChiras, J | |
773 | 0 |
_tNeurology _gvol. 61 _gno. 6 _gp. 839-41 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.61.6.839 _zAvailable from publisher's website |
999 |
_c14265547 _d14265547 |